Searched for
TROKENDI XR
Momentum Pick: Zydus Lifesciences can gain 8-20% based on these technical, fundamental triggersZydus Lifesciences has given returns of more than 35% over a 12-month period outperforming the Nifty50 which has given 1% returns during th...- Buy Zydus Lifesciences, target price Rs 572: Sharekhan by BNP ParibasZydus Lifesciences, incorporated in the year 1995, is a Large Cap company (having a market cap of Rs 48616.16 Crore) operating in Pharmaceu...
- Thirteen stocks in focus on Wednesday, 8 March 2017Hero MotoCorp on Tuesday declared an interim dividend of Rs 55 per equity share for the current financial year.
- Cadila inks pact with Supernus Pharma to settle patent issueCadila Healthcare have finalised an agreement with Supernus Pharmaceuticals Inc to settle all outstanding patent litigation.
Load More